NEON THERAPEUTICS INC - COM (NTGN)

CUSIP: 64050Y100

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / COM
Total 13F shares
19,708,351
Share change
-112,544
Total reported value
$127,311,827
Price per share
$6.46
Number of holders
49
Value change
+$95,227
Number of buys
31
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 64050Y100?
CUSIP 64050Y100 identifies NTGN - NEON THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEON THERAPEUTICS INC - COM (NTGN) as of Q1 2019

As of 31 Mar 2019, NEON THERAPEUTICS INC - COM (NTGN) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,708,351 shares. The largest 10 holders included TRV GP III, LLC, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, ArrowMark Colorado Holdings LLC, BlackRock Inc., MEITAV DASH INVESTMENTS LTD, VANGUARD GROUP INC, HARVARD MANAGEMENT CO INC, Endurant Capital Management LP, and Partner Fund Management, L.P.. This page lists 49 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.